Back to Search Start Over

Ursodeoxycholic acid therapy for chronic type C hepatitis: A multicenter, dose-finding trial

Authors :
Hidenori Ohki
Makoto Kako
Makoto Yoshiba
Hiroshi Nakajima
Kazunori Matsumoto
Tohru Narita
Fumio Sugata
Kazuo Kamii
Kazuhiko Miyake
Masami Yamanaka
Kazuhiko Sekiyama
Toshio Aoyagi
Hajime Takikawa
Source :
Current Therapeutic Research. 55:16-21
Publication Year :
1994
Publisher :
Elsevier BV, 1994.

Abstract

Ursodeoxycholic acid (UDCA) was administered orally for 12 weeks to 40 patients with chronic type C hepatitis. Patients were randomly assigned to receive UDCA 150 mg/day (n = 20) or 450 mg/day (n = 20). In the 450-mg group, alanine aminotransferase (ALT) decreased significantly ( P P P P

Details

ISSN :
0011393X
Volume :
55
Database :
OpenAIRE
Journal :
Current Therapeutic Research
Accession number :
edsair.doi...........d3e55b871e824b85b7d63e4bdcc71e5b
Full Text :
https://doi.org/10.1016/s0011-393x(05)80073-6